Jianfang Jin
Directeur Général chez American Evans Group Corp.
Postes actifs de Jianfang Jin
Sociétés | Poste | Début | Fin |
---|---|---|---|
American Evans Group Corp. | Directeur Général | - | - |
President | - | - | |
Beijing Evans Information & Consulting Co., Ltd. | Corporate Officer/Principal | - | - |
Historique de carrière de Jianfang Jin
Anciens postes connus de Jianfang Jin
Sociétés | Poste | Début | Fin |
---|---|---|---|
GENIX PHARMACEUTICALS CORPORATION | Directeur/Membre du Conseil | 10/10/2007 | 11/03/2019 |
Directeur Général | 10/10/2007 | 11/03/2019 | |
President | 10/10/2007 | 11/03/2019 | |
Secrétaire Général | 07/09/2010 | 11/03/2019 | |
Tianjin Angen Biotech Co., Ltd. | President | 01/05/2003 | 01/06/2008 |
Angen Biotech Co. Ltd. | President | - | 01/06/2008 |
SinoPharm, Inc.
SinoPharm, Inc. Pharmaceuticals: MajorHealth Technology SinoPharm, Inc. produces and develops generic pharmaceuticals. The company's products include medaxol, active pharmaceutical ingredient (API), and anti-cancer compound extracted from the Chinese Yew tree, and docetaxel. The company was established in 2001 and is headquartered in Richmond, Canada. | Directeur Financier/CFO | 01/09/2002 | 01/01/2008 |
XTACY THERAPEUTICS CORP. | Directeur/Membre du Conseil | 01/10/2008 | - |
Formation de Jianfang Jin
Purdue University | Graduate Degree |
Nankai University | Undergraduate Degree |
Statistiques
Internationale
Chine | 5 |
Canada | 4 |
Etats-Unis | 3 |
Opérationnelle
President | 4 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectorielle
Consumer Services | 3 |
Health Technology | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
XTACY THERAPEUTICS CORP. | Finance |
GENIX PHARMACEUTICALS CORPORATION | Health Technology |
Entreprise privées | 5 |
---|---|
SinoPharm, Inc.
SinoPharm, Inc. Pharmaceuticals: MajorHealth Technology SinoPharm, Inc. produces and develops generic pharmaceuticals. The company's products include medaxol, active pharmaceutical ingredient (API), and anti-cancer compound extracted from the Chinese Yew tree, and docetaxel. The company was established in 2001 and is headquartered in Richmond, Canada. | Health Technology |
American Evans Group Corp. | |
Tianjin Angen Biotech Co., Ltd. | |
Beijing Evans Information & Consulting Co., Ltd. | |
Angen Biotech Co. Ltd. |
- Bourse
- Insiders
- Jianfang Jin
- Expérience